Patents by Inventor Yongmoon Han

Yongmoon Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040247611
    Abstract: This application relates to assays for identifying pathogen-ligand interactions under shear conditions, and to pathogen adhesin molecules and peptides identified thereby. Such adhesin molecules and peptides may be used as vaccines or therapeutic agents in the prevention and treatment of microbial infections.
    Type: Application
    Filed: February 19, 2004
    Publication date: December 9, 2004
    Applicants: Montana State University, Ligocyte Pharmaceuticals, Inc.
    Inventors: Robert Bargatze, John Jutila, Jim Cutler, Yongmoon Han, Barry Pyle
  • Publication number: 20030223938
    Abstract: The present invention relates to nanoparticles comprised of a carrier, particularly polymerized lipids, and ligands displayed on the carrier, wherein the ligands form a polyvalent binding unit that is effective to produce a specific interaction between the nanoparticle and receptors on a target, particularly under physiologically relevant shear conditions.
    Type: Application
    Filed: April 14, 2003
    Publication date: December 4, 2003
    Inventors: John O. Nagy, Robert F. Bargatze, John W. Jutila, Jim E. Cutler, Yongmoon Han, Pati M. Glee, David Pascual
  • Patent number: 6630146
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannan of C. albicans. Monoclonal antibodies for use in passive immunization against candidal infections.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: October 7, 2003
    Assignee: Montana State University
    Inventors: Jim E. Cutler, Yongmoon Han
  • Publication number: 20030072775
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannan of C. albicans, peptide mimotopes of phosphomannan epitopes, or polynucleotides encoding the peptide mimotopes. Monoclonal antibodies for use in passive immunization against candida infections are also provided.
    Type: Application
    Filed: February 14, 2002
    Publication date: April 17, 2003
    Applicant: The Research and Development Institute Inc.
    Inventors: Jim E. Cutler, Yongmoon Han, Pati M. Glee, Bruce L. Granger
  • Patent number: 6488929
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to the infection by C. albicans. The composition includes phosphomannan of C. albicans. Monoclonal antibodies for use in passive immunization against candidal infections.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: December 3, 2002
    Assignee: Montana State University
    Inventors: Jim E. Cutler, Yongmoon Han
  • Publication number: 20020160009
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannan of C. albicans. Monoclonal antibodies for use in passive immunization against candidal infections.
    Type: Application
    Filed: July 12, 1999
    Publication date: October 31, 2002
    Applicant: MORGAN, LEWIS AND BOCKUIS LLP
    Inventors: JIM E. CUTLER, YONGMOON HAN
  • Patent number: 6403090
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannan of C. albicans, peptide mimotopes of phosphomannan epitopes, or polynucleotides encoding the peptide mimotopes. Monoclonal antibodies for use in passive immunization against candida infections are also provided.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: June 11, 2002
    Assignee: The Research and Development Institute Inc.
    Inventors: Jim E. Cutler, Yongmoon Han
  • Publication number: 20020054886
    Abstract: A composition, pharmaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannan of C. albicans. Monoclonal antibodies for use in passive immunization against candidal infections.
    Type: Application
    Filed: December 11, 2000
    Publication date: May 9, 2002
    Applicant: The Research and Development Institute Inc.
    Inventors: Jim E. Cutler, Yongmoon Han
  • Patent number: 5578309
    Abstract: A composition, pharamaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannoprotein which contains adhesins from C. albicans.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 26, 1996
    Assignee: The Research and Development Institute, Inc.
    Inventors: Jim E. Cutler, Yongmoon Han